Explore the complex challenges of proving bioequivalence for combination products, from FDC interactions to drug-device user interface hurdles and regulatory traps.
Explore how blockchain technology is eliminating counterfeit medicines and securing the generic drug supply chain through immutable digital pedigrees and DSCSA compliance.